Hector Rudilla

Mr. Hector Rudilla


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2016 in Molecules
Verified
Journal Article
Open access
PDF file
HRHector Rudilla
Hector Rudilla
EFEster Fusté
Ester Fusté
YVYolanda Cajal Visa
Yolanda Cajal Visa
Francesc RabanalFrancesc Rabanal
Francesc Rabanal
TVTeresa Vinuesa
Teresa Vinuesa
Miguel VinasMiguel Vinas
Miguel Vinas
The aim was to explore the antimicrobial activity of a synthetic peptide (AMP38) and its synergy with imipenem against imipenem-resistant Pseudomonas aeruginosa. The main mechanism of imipenem resistance is the loss or alteration of protein OprD. Time-kill and minimal biofilm eradication concentration (MBEC) determinations were carried out by using clinical imipenem-resistant strains. AMP38 was markedly synergistic with imipenem when determined in imipenem-resistant P. aeruginosa. MBEC obtained for the combination of AMP38 and imipenem was of 62.5 μg/mL, whereas the MBEC of each antimicrobial separately was 500 μg/mL. AMP38 should be regarded as a promising antimicrobial to fight MDR P. aeruginosa infections. Moreover, killing effect and antibiofilm activity of AMP38 plus imipenem was much higher than that of colistin plus imipenem.